Journal of Medical Virology,
Journal Year:
2023,
Volume and Issue:
95(2)
Published: Jan. 5, 2023
Therapeutic
approaches
with
immune-modulatory
effects
such
as
probiotics
and
prebiotics
adjuvant
therapy
may
be
essential
to
combat
against
COVID-19
pandemic.
The
present
trial
aimed
reveal
the
efficacy
of
synbiotic
supplementation
on
clinical
paraclinical
outcomes
hospitalized
patients.
current
randomized
placebo-controlled
enrolled
78
patients
confirmed
infection.
Participants
were
randomly
allocated
intervention
control
groups
that
received
or
placebo
capsules
twice
daily
for
2
weeks,
respectively.
capsule
contains
multi-strain
Lactobacillus
(L.)
rhamnosus,
L.
helveticus,
casei,
Bifidobacterium
(B.)
lactis,
acidophilus,
B.
breve,
bulgaricus,
longum,
plantarum,
bifidum,
gasseri,
Streptococcus
(S.)
thermophilus
(109
CFU),
well
fructooligosaccharides
prebiotic
agent.
Besides
features,
levels
proinflammatory
interleukin-6
(IL-6),
C-reactive
protein
(CRP),
erythrocyte
sedimentation
rate
(ESR),
liver
renal
function
markers,
hematological
parameters,
assessed
during
follow-up.
serum
level
IL-6
was
significantly
decreased
in
group
compared
after
weeks
(p
=
0.002).
A
significant
difference
found
regarding
count
white
blood
cells
(WBC)
within
from
pre
post-treatment
0.004).
ESR
0.935)
CRP
0.952)
had
a
higher
reduction
trend
relative
placebo,
no
between-group
differences.
Other
findings
statistical
differences
between
groups.
Our
results
provide
support
can
effective
modulate
inflammatory
responses
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(2), P. 234 - 234
Published: Jan. 23, 2024
Probiotics,
known
to
be
live
microorganisms,
have
been
shown
improve
or
restore
the
gut
microbiota,
which
in
turn
has
linked
improved
health.
It
is
believed
that
probiotics
are
modern
equivalent
of
a
panacea,
with
claims
they
may
treat
prevent
different
diseases
both
children
and
adults
(e.g.,
from
colic
babies
cardiovascular
disease,
respiratory
infection,
cancer
adults).
Ever
since
early
2000s,
probiotic-based
fermented
foods
had
resurgence
popularity,
mostly
due
made
regarding
their
health
benefits.
Fermented
associated
prevention
irritable
bowel
syndrome,
lactose
intolerance,
gastroenteritis,
obesity,
but
also
other
conditions
such
as
chronic
diarrhea,
allergies,
dermatitis,
bacterial
viral
infections,
all
closely
related
an
unhealthy
lifestyle.
Recent
ongoing
developments
microbiome/microbiota
science
given
us
new
research
directions
for
probiotics.
The
types,
mechanisms,
applications
studied
so
far,
those
currently
under
study,
great
potential
change
scientific
understanding
probiotics’
nutritional
human
care.
expansion
fields
study
microbiome
involvement
its
improvement
foreshadow
era
significant
changes.
An
expanding
range
candidate
probiotic
species
emerging
can
address
newly
elucidated
data-driven
microbial
niches
host
targets.
In
field,
variants
microbiome-modulating
interventions
being
developed,
including
prebiotics,
symbiotics,
postbiotics,
consortia,
biotherapeutic
products,
genetically
modified
organisms,
renewed
interest
polyphenols,
fibers,
ensure
This
manuscript
aims
analyze
recent,
emerging,
anticipated
trends
(sources,
doses,
mechanism
action,
administered,
side
effects,
risks)
create
vision
development
areas
influence
field.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: May 31, 2022
Respiratory
diseases
cause
a
high
incidence
and
mortality
worldwide.
As
natural
immunobiotic,
Lactobacillus
has
excellent
immunomodulatory
ability.
Administration
of
some
species
can
alleviate
the
symptoms
respiratory
such
as
tract
infections,
asthma,
lung
cancer
cystic
fibrosis
in
animal
studies
clinical
trials.
The
beneficial
effect
on
is
strain
dependent.
Moreover,
efficacy
may
be
affected
by
many
factors,
bacteria
dose,
timing
host
background.
Here,
we
summarized
administered
common
with
focus
mechanism
safety
regulating
immunity.
Biomolecules,
Journal Year:
2022,
Volume and Issue:
12(10), P. 1442 - 1442
Published: Oct. 9, 2022
Infectious
diseases
have
been
a
threat
to
human
health
globally.
The
relentless
efforts
and
research
enabled
us
overcome
most
of
the
through
use
antiviral
antibiotic
agents
discovered
employed.
Unfortunately,
microorganisms
capability
adapt
mutate
over
time
resistance
ensues.
There
are
many
challenges
in
treating
infections
such
as
failure
respond
therapeutic
agents,
which
has
led
more
chronic
infections,
complications,
preventable
loss
life.
Thus,
multidisciplinary
approach
collaboration
is
warranted
create
potent,
effective,
versatile
therapies
prevent
eradicate
old
newly
emerging
diseases.
In
recent
past,
natural
medicine
proven
its
effectiveness
against
various
illnesses.
Most
pharmaceutical
currently
used
can
trace
their
origin
products
one
way,
shape,
or
form.
full
potential
yet
be
realized,
numerous
resources
not
explored
analyzed.
This
merits
continuous
support
analysis
ancient
treatment
systems
explore
employ
them
an
alternative
principal
therapy.
Frontiers in Microbiology,
Journal Year:
2024,
Volume and Issue:
14
Published: Jan. 5, 2024
The
imbalance
of
microbial
composition
and
diversity
in
favor
pathogenic
microorganisms
combined
with
a
loss
beneficial
gut
microbiota
taxa
results
from
factors
such
as
age,
diet,
antimicrobial
administration
for
different
infections,
other
underlying
medical
conditions,
etc.
Probiotics
are
known
their
capacity
to
improve
health
by
stimulating
the
indigenous
microbiota,
enhancing
host
immunity
resistance
infection,
helping
digestion,
carrying
out
various
functions.
Concurrently,
metabolites
produced
these
microorganisms,
termed
postbiotics,
which
include
compounds
like
bacteriocins,
lactic
acid,
hydrogen
peroxide,
contribute
inhibiting
wide
range
bacteria.
This
review
presents
an
update
on
using
probiotics
managing
treating
human
diseases,
including
complications
that
may
emerge
during
or
after
COVID-19
infection.
Food Bioengineering,
Journal Year:
2024,
Volume and Issue:
3(1), P. 41 - 64
Published: March 1, 2024
Abstract
Probiotics
have
become
increasingly
popular
over
the
past
two
decades
due
to
continuously
expanding
scientific
evidence
indicating
their
beneficial
effects
on
human
health.
Therefore,
they
been
applied
in
food
industry
produce
functional
food,
which
plays
a
significant
role
health
and
reduces
disease
risk.
However,
maintaining
viability
of
probiotics
targeting
successful
delivery
gastrointestinal
tract
remain
challenging
tasks
applications.
Specifically,
this
paper
reviews
potentially
properties
probiotics,
highlighting
use
challenges
application
associated
benefits.
Of
foremost
importance,
also
explores
potential
underlying
molecular
mechanisms
enhanced
effect
epithelial
cells,
including
discussion
various
surface
adhesion‐related
proteins
probiotic
cell
that
facilitate
colonization.
Signal Transduction and Targeted Therapy,
Journal Year:
2025,
Volume and Issue:
10(1)
Published: Jan. 7, 2025
Abstract
The
mucosal
immune
system,
as
the
most
extensive
peripheral
network,
serves
frontline
defense
against
a
myriad
of
microbial
and
dietary
antigens.
It
is
crucial
in
preventing
pathogen
invasion
establishing
tolerance.
A
comprehensive
understanding
immunity
essential
for
developing
treatments
that
can
effectively
target
diseases
at
their
entry
points,
thereby
minimizing
overall
impact
on
body.
Despite
its
importance,
our
knowledge
remains
incomplete,
necessitating
further
research.
outbreak
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
underscored
critical
role
disease
prevention
treatment.
This
systematic
review
focuses
dynamic
interactions
between
mucosa-associated
lymphoid
structures
related
diseases.
We
delve
into
basic
functions
these
tissues
during
processes
explore
intricate
regulatory
networks
mechanisms
involved.
Additionally,
we
summarize
novel
therapies
clinical
research
advances
immunity-related
also
addresses
challenges
vaccines,
which
aim
to
induce
specific
responses
while
maintaining
tolerance
non-pathogenic
microbes.
Innovative
therapies,
such
nanoparticle
vaccines
inhalable
antibodies,
show
promise
enhancing
offer
potential
improved
Annals of Clinical Microbiology and Antimicrobials,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: April 20, 2025
Abstract
Background
Long
COVID
is
a
complex,
heterogeneous
syndrome
affecting
over
four
hundred
million
people
globally.
There
are
few
recommendations,
and
no
formal
training
exists
for
medical
professionals
to
assist
with
clinical
evaluation
management
of
patients
COVID.
More
research
into
the
pathology,
cellular,
molecular
mechanisms
COVID,
treatments
needed.
The
goal
this
work
disseminate
essential
information
about
recommendations
definition,
diagnosis,
treatment,
social
issues
physicians,
researchers,
policy
makers
address
escalating
global
health
crisis.
Methods
A
3-round
modified
Delphi
consensus
methodology
was
distributed
internationally
179
healthcare
professionals,
persons
lived
experience
in
28
countries.
Statements
were
combined
specific
areas:
research,
society.
Results
survey
resulted
187
comprehensive
statements
reaching
strongest
areas
being
diagnosis
assessment,
general
research.
We
establish
conditions
different
subgroups
within
umbrella.
Clear
reached
that
impacts
COVID-19
infection
on
children
should
be
priority,
additionally
need
determine
effects
societies
economies.
it
affects
nervous
system
other
organs
not
likely
observed
initial
symptoms.
note,
biomarkers
critically
needed
these
issues.
Conclusions
This
forms
guidance
spectrum
as
disease
reinforces
translational
large-scale
treatment
trials
protocols.
Frontiers in Microbiology,
Journal Year:
2022,
Volume and Issue:
13
Published: Aug. 12, 2022
The
coronavirus
disease
2019
(COVID-19)
is
an
infectious
caused
by
severe
acute
respiratory
syndrome
2
(SARS-CoV-2).
According
to
the
World
Health
Organization
statistics,
more
than
500
million
individuals
have
been
infected
and
6
deaths
resulted
worldwide.
Although
COVID-19
mainly
affects
system,
considerable
evidence
shows
that
digestive,
cardiovascular,
nervous,
reproductive
systems
can
all
be
involved.
Angiotensin-converting
enzyme
(AEC2),
target
of
SARS-CoV-2
invasion
host
distributed
in
gastrointestinal
tract.
Studies
found
microbiota
contributes
onset
progression
many
diseases,
including
COVID-19.
Here,
we
firstly
conclude
characterization
respiratory,
gut,
oral
microbial
dysbiosis,
bacteria,
fungi,
viruses.
Then
explore
potential
mechanisms
involvement
Microbial
dysbiosis
could
influence
complex
interactions
with
immunity.
Moreover,
may
impact
on
through
their
metabolites
or
modulation
ACE2
expression.
Subsequently,
generalize
as
diagnostic
markers
for
patients
its
possible
association
post-acute
(PACS)
relapse
after
recovery.
Finally,
proposed
directed
microbiota-targeted
treatments
from
perspective
gut
microecology
such
probiotics
prebiotics,
fecal
transplantation
antibiotics,
other
interventions
traditional
Chinese
medicine,
vaccines,
ACE2-based
treatments.